Selumetinib, Differentiated Thyroid Cancer , AZD6244
Showing 9976 - 10000 of >10,000
Blood, Urine, and Stool to Monitor MetastaticColorectal Cancers
Completed
- Stage III Colorectal Cancer AJCC v8
- +7 more
- Biopsy
- +3 more
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Nov 16, 2021
Myeloid Derived Suppressor Cells Clinical Assay in Finding
Recruiting
- Healthy Subject
- +5 more
- Computed Tomography
- +3 more
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Nov 16, 2021
Microbiome on Breast Cancer Radiotherapy Toxicity
Recruiting
- DCIS
- Invasive Breast Cancer
- Stool sample
- Skin Swab Sample
-
Cleveland, OhioCleveland Clinic, Case Comprehensive Cancer Center
Jan 30, 2023
Integrated Chinese Medicine With Western Medicine for Reduction
Completed
- Myelosuppression
- Chemotherapy and Integrated Chinese Medicine With Western Medicine for cancer treatment
- (no location specified)
Jun 28, 2022
Non Small Cell Lung Cancer Trial in Nashville (AMG 510, MVASI)
Recruiting
- Non Small Cell Lung Cancer
- AMG 510
- MVASI
-
Nashville, TennesseeVanderbilt Ingram Cancer Center
Jun 28, 2022
Pancreatic Cancer Trial in Tampa (Fitbit Data Collection, Nutrition Counseling, Fact G Survey)
Recruiting
- Pancreatic Cancer
- Fitbit Data Collection
- +4 more
-
Tampa, FloridaMoffitt Cancer Center
Jun 29, 2022
Esophageal Cancer, Esophagogastric Junction Cancer Trial in Lexington (drug, radiation, procedure)
Not yet recruiting
- Esophageal Cancer
- Esophagogastric Junction Cancer
- Intravenous Tislelizumab
- +3 more
-
Lexington, KentuckyUniversity of Kentucky
Feb 21, 2022
DevelopingNew MRI Technique to Understand Changes in Brain
Recruiting
- Brain Metastases
- +3 more
- CEST-MRF
-
New York, New YorkMemorial Sloan Kettering Cancer Center (All Protocol Activities)
Sep 27, 2022
Cancer Trial in Strasbourg (Snoezelen session)
Recruiting
- Cancer
- Snoezelen session
-
Strasbourg, FranceInstitut de cancérologie Strasbourg Europe
Aug 2, 2022
Colonic Tumors Malignant Trial in Russian Federation (Colonic resection with D2 lymph node dissection, Colonic resection with D3
Active, not recruiting
- Colonic Neoplasms Malignant
- Colonic resection with D2 lymph node dissection
- Colonic resection with D3 lymph node dissection
-
Krasnodar, Russian Federation
- +11 more
Apr 20, 2022
Colorectal Cancer Trial in Chengdu (lidocaine, Placebo)
Recruiting
- Colorectal Cancer
- lidocaine
- Placebo
-
Chengdu, Sichuan, ChinaWest China Hospital, Sichuan University
Jun 24, 2023
Prostatic Tumors, Prostatic Diseases, Prostate Cancer Trial in Portland (68GA PSMA-HBED-CC)
Approved for marketing
- Prostatic Neoplasms
- +4 more
- 68GA PSMA-HBED-CC
-
Portland, OregonOHSU Knight Cancer Institute
Mar 11, 2022
CAR T-Cell Therapy Trial in Shenzhen (HEC-016(0.5×10^6 CAR-T Cells), HEC-016(0.5×10^6.5 CAR-T Cells), HEC-016(0.5×10^7 CAR-T
Recruiting
- CAR T-Cell Therapy
- HEC-016(0.5×10^6 CAR-T Cells)
- +2 more
-
Shenzhen, Guangdong, ChinaShenzhen Luohu Hospital
Mar 3, 2022
Target Therapy for Brain Metastases With EGFR Mutation
Not yet recruiting
- Brain Metastases
- Surgery or Radiotherapy
- before or after target therapy
- (no location specified)
Nov 8, 2022
Tobacco-Related Carcinoma Trial in United States (Best Practice, Survey Administration, Tobacco Cessation Counseling)
Recruiting
- Tobacco-Related Carcinoma
- Best Practice
- +3 more
-
Lexington, Kentucky
- +3 more
Apr 23, 2022
Refractory Plasma Cell Myeloma, Recurrent Plasma Cell Myeloma Trial in United States (ixazomib citrate, dexamethasone,
Active, not recruiting
- Refractory Plasma Cell Myeloma
- Recurrent Plasma Cell Myeloma
- ixazomib citrate
- +2 more
-
Scottsdale, Arizona
- +4 more
Mar 28, 2022
Triple Negative Breast Cancer Trial in Portugal, Spain (Ipatasertib, Capecitabine, Eribulin)
Recruiting
- Triple Negative Breast Cancer
- Ipatasertib
- +4 more
-
Amadora, Lisboa, Portugal
- +16 more
Jun 10, 2022
Rheumatoid Arthritis Trial in Saint Paul (Atorvastatin, Pravastatin, Rosuvastatin)
Completed
- Rheumatoid Arthritis
- Atorvastatin
- +3 more
-
Saint Paul, MinnesotaPrism Research, LLC
May 26, 2022
Deleterious BRCA1 Gene Mutation, Deleterious BRCA2 Gene Mutation, Endometrial Adenocarcinoma Trial in Houston (Copanlisib,
Recruiting
- Deleterious BRCA1 Gene Mutation
- +10 more
-
Houston, TexasM D Anderson Cancer Center
Aug 23, 2022
Pancreatic Ductal Adenocarcinoma, Pancreas Adenocarcinoma, Pancreas Cancer Trial in Kansas City (Enfortumab vedotin)
Recruiting
- Pancreatic Ductal Adenocarcinoma
- +2 more
- Enfortumab vedotin
-
Kansas City, KansasUniversity of Kansas Cancer Center
Jun 23, 2023
Rectal Cancer Trial in Montpellier, Clermont-Ferrand (Biological collection)
Recruiting
- Rectal Cancer
- Biological collection
-
Montpellier, Hérault, France
- +1 more
Jan 21, 2022
MGMT-Methylated Glioblastoma, Recurrent Glioblastoma, IDH-Wildtype Trial (Selinexor, Temozolomide)
Not yet recruiting
- MGMT-Methylated Glioblastoma
- Recurrent Glioblastoma, IDH-Wildtype
- (no location specified)
Jun 28, 2022
Social Experiences of Adolescents and Young Adults With Cancer
Recruiting
- Childhood Cancer
- +2 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Apr 1, 2022
Breast Cancer Trial in Barcelona, Madrid, Valencia (Talimogene laherparepvec, Atezolizumab)
Active, not recruiting
- Breast Cancer
- Talimogene laherparepvec
- Atezolizumab
-
Barcelona, Spain
- +3 more
Sep 27, 2022